Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 8/2020

23-03-2020

Psychotropic polypharmacy and its association with health-related quality of life among cancer survivors in the USA: a population-level analysis

Auteurs: Ami Vyas, Ghadah Alghaith, Meghan Hufstader-Gabriel

Gepubliceerd in: Quality of Life Research | Uitgave 8/2020

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Cancer survivors that use multiple psychotropic medications are at an increased risk of psychotropic polypharmacy. We examined the association between psychotropic polypharmacy and health-related quality of life (HRQoL) among cancer survivors living in the USA.

Methods

We used the Medical Expenditure Panel Survey (MEPS) data for 2010, 2012, and 2014 to identify adult cancer survivors. Psychotropic polypharmacy was defined as use of at least two classes of psychotropic prescription medications. The physical component summary (PCS) and the mental component summary (MCS) were obtained from the 12-item Short Form Health Survey version 2 to measure HRQoL. Adjusted ordinary least square regressions were performed to evaluate the association between psychotropic polypharmacy and HRQoL.

Results

Among 31 million US cancer survivors (weighted from a sample of 2609), 16.3% reported psychotropic polypharmacy. Lung cancer survivors had the highest prevalence of psychotropic polypharmacy (22.5%), followed by survivors of breast cancer (17.8%), colorectal, and other gastrointestinal cancers (16.0%). The unadjusted PCS and MCS scores for those with psychotropic polypharmacy were significantly lower than those without psychotropic polypharmacy, overall, and for each cancer type. In multivariable regressions, cancer survivors with psychotropic polypharmacy had significantly lower PCS scores (β =  − 3.63, p < 0.0001) and MCS scores (β =  − 2.28, p = 0.0138) compared to those without psychotropic polypharmacy.

Conclusion

Cancer survivors requiring multiple psychotropic medications have poorer quality of life.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Bluethmann, S. M., Mariotto, A. B., & Rowland, J. H. (2016). Anticipating the “Silver Tsunami”: Prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiology, Biomarkers & Prevention, 25, 1029–1036. CrossRef Bluethmann, S. M., Mariotto, A. B., & Rowland, J. H. (2016). Anticipating the “Silver Tsunami”: Prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiology, Biomarkers & Prevention, 25, 1029–1036. CrossRef
2.
go back to reference Singer, S., Das-Munshi, J., & Brahler, E. (2010). Prevalence of mental health conditions in cancer patients in acute care-a meta-analysis. Annals of Oncology, 21, 925–930. CrossRef Singer, S., Das-Munshi, J., & Brahler, E. (2010). Prevalence of mental health conditions in cancer patients in acute care-a meta-analysis. Annals of Oncology, 21, 925–930. CrossRef
3.
go back to reference Mitchell, A. J., Chan, M., Bhatti, H., et al. (2011). Prevalence of depression, anxiety, and adjustment disorders in oncological, haematological, and palliative care settings: A meta-analysis of 94 interview-based studies. Lancet, 12(2), 160–174. CrossRef Mitchell, A. J., Chan, M., Bhatti, H., et al. (2011). Prevalence of depression, anxiety, and adjustment disorders in oncological, haematological, and palliative care settings: A meta-analysis of 94 interview-based studies. Lancet, 12(2), 160–174. CrossRef
4.
go back to reference Ng, C. G., Boks, M. P., Smeets, H. M., Zainal, N. Z., & de Wit, N. J. (2013). Prescription patterns for psychotropic drugs in cancer patients: A large population study in the Netherlands. Psychooncology, 22(4), 762–767. CrossRef Ng, C. G., Boks, M. P., Smeets, H. M., Zainal, N. Z., & de Wit, N. J. (2013). Prescription patterns for psychotropic drugs in cancer patients: A large population study in the Netherlands. Psychooncology, 22(4), 762–767. CrossRef
5.
go back to reference Farriols, C., Ferrandez, O., Planas, J., Ortiz, P., Mojal, S., & Ruiz, A. I. (2012). Changes in the prescription of psychotropic drugs in the palliative care of advanced cancer patients over a seven-year period. Journal of Pain and Symptom Management, 43(5), 945–952. CrossRef Farriols, C., Ferrandez, O., Planas, J., Ortiz, P., Mojal, S., & Ruiz, A. I. (2012). Changes in the prescription of psychotropic drugs in the palliative care of advanced cancer patients over a seven-year period. Journal of Pain and Symptom Management, 43(5), 945–952. CrossRef
6.
go back to reference Punekar, R. S., Short, P. F., & Moran, J. R. (2012). Use of psychotropic medications by US cancer survivors. Psychooncology, 21(11), 1237–1243. CrossRef Punekar, R. S., Short, P. F., & Moran, J. R. (2012). Use of psychotropic medications by US cancer survivors. Psychooncology, 21(11), 1237–1243. CrossRef
7.
go back to reference Bruera, E., & Neumann, C. (1998). The uses of psychotropics in symptom management in advanced cancer. Psychooncology, 7(4), 346–358. CrossRef Bruera, E., & Neumann, C. (1998). The uses of psychotropics in symptom management in advanced cancer. Psychooncology, 7(4), 346–358. CrossRef
8.
go back to reference Thekdi, S. M., Irarrazaval, M. E., & Dunn, L. B. (2012). Psychopharmacological interventions. In L. Grass & M. Riba (Eds.), Clinical psycho-oncology: An international perspective (pp. 109–126). Chichester: Willey-Blackwell. CrossRef Thekdi, S. M., Irarrazaval, M. E., & Dunn, L. B. (2012). Psychopharmacological interventions. In L. Grass & M. Riba (Eds.), Clinical psycho-oncology: An international perspective (pp. 109–126). Chichester: Willey-Blackwell. CrossRef
9.
go back to reference Mojtabai, R., & Olfson, M. (2010). National trends in psychotropic medication polypharmacy in office-based psychiatry. Archives of General Psychiatry, 67(1), 26–36. CrossRef Mojtabai, R., & Olfson, M. (2010). National trends in psychotropic medication polypharmacy in office-based psychiatry. Archives of General Psychiatry, 67(1), 26–36. CrossRef
10.
go back to reference Correll, C. U., & Gallego, J. A. (2012). Antipsychotic polypharmacy: A comprehensive evaluation of relevant correlates of a long-standing clinical practice. Psychiatric Clinics of North America, 35(3), 661–681. CrossRef Correll, C. U., & Gallego, J. A. (2012). Antipsychotic polypharmacy: A comprehensive evaluation of relevant correlates of a long-standing clinical practice. Psychiatric Clinics of North America, 35(3), 661–681. CrossRef
11.
go back to reference Sandson, N. B., Armstrong, S. C., & Cozza, K. L. (2005). An overview of psychotropic drug-drug interactions. Psychosomatics, 46(5), 464–494. CrossRef Sandson, N. B., Armstrong, S. C., & Cozza, K. L. (2005). An overview of psychotropic drug-drug interactions. Psychosomatics, 46(5), 464–494. CrossRef
12.
go back to reference Yap, K. Y., Tay, W. L., Chui, W. K., & Chan, A. (2011). Clinically relevant drug interactions between anticancer drugs and psychotropic agents. European Journal of Cancer Care (England), 20(1), 6–32. CrossRef Yap, K. Y., Tay, W. L., Chui, W. K., & Chan, A. (2011). Clinically relevant drug interactions between anticancer drugs and psychotropic agents. European Journal of Cancer Care (England), 20(1), 6–32. CrossRef
13.
go back to reference Aroke, H., Vyas, A., Buchanan, A., & Kogut, S. (2019). Prevalence of psychotropic polypharmacy and associated healthcare utilization during initial phase of care among adults with cancer in USA. Drugs Real World Outcomes, 6(2), 73–82. CrossRef Aroke, H., Vyas, A., Buchanan, A., & Kogut, S. (2019). Prevalence of psychotropic polypharmacy and associated healthcare utilization during initial phase of care among adults with cancer in USA. Drugs Real World Outcomes, 6(2), 73–82. CrossRef
14.
go back to reference Vyas, A., Kogut, S., & Aroke, H. (2019). Real-world direct healthcare costs associated with psychotropic polypharmacy among adults with common cancer types in the United States. Journal of Managed Care & Specialty Pharmacy, 25(5), 555–565. CrossRef Vyas, A., Kogut, S., & Aroke, H. (2019). Real-world direct healthcare costs associated with psychotropic polypharmacy among adults with common cancer types in the United States. Journal of Managed Care & Specialty Pharmacy, 25(5), 555–565. CrossRef
15.
go back to reference Harrison, S. L., Bradley, C., Milte, R., et al. (2018). Psychotropic medications in older people in residential care facilities and associations with quality of life: A cross-sectional study. BMC Geriatrics, 18, 60. CrossRef Harrison, S. L., Bradley, C., Milte, R., et al. (2018). Psychotropic medications in older people in residential care facilities and associations with quality of life: A cross-sectional study. BMC Geriatrics, 18, 60. CrossRef
16.
go back to reference Thompson Coon, J., Abbott, R., Rogers, M., et al. (2014). Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: A systematic review. Journal of the American Medical Directors Association, 15(10), 706–718. CrossRef Thompson Coon, J., Abbott, R., Rogers, M., et al. (2014). Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: A systematic review. Journal of the American Medical Directors Association, 15(10), 706–718. CrossRef
19.
go back to reference Ware, J., Jr., Kosinski, M., & Keller, S. D. (1996). A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34, 220–233. CrossRef Ware, J., Jr., Kosinski, M., & Keller, S. D. (1996). A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34, 220–233. CrossRef
20.
go back to reference Ware, J., Jr., Kosinski, M., Turner-Bowker, D. M., & Gandek, B. (2002). SF-12v2: How to score version 2 of the SF-12 health survey (with a supplement documenting version 1). Lincoln, RI: QualityMetric Inc. Ware, J., Jr., Kosinski, M., Turner-Bowker, D. M., & Gandek, B. (2002). SF-12v2: How to score version 2 of the SF-12 health survey (with a supplement documenting version 1). Lincoln, RI: QualityMetric Inc.
21.
go back to reference Braun, I. M., Rao, S. R., Meyer, F. L., & Fedele, G. (2015). Patterns of psychiatric medication use among nationally representative long-term cancer survivors and controls. Cancer, 121, 132–138. CrossRef Braun, I. M., Rao, S. R., Meyer, F. L., & Fedele, G. (2015). Patterns of psychiatric medication use among nationally representative long-term cancer survivors and controls. Cancer, 121, 132–138. CrossRef
22.
go back to reference Jones, S. M., Rosenberg, D., Ludman, E., & Arterburn, D. (2015). Medical comorbidity and psychotropic medication fills in older adults with breast or prostate cancer. Supportive Care in Cancer, 23(10), 3005–3009. CrossRef Jones, S. M., Rosenberg, D., Ludman, E., & Arterburn, D. (2015). Medical comorbidity and psychotropic medication fills in older adults with breast or prostate cancer. Supportive Care in Cancer, 23(10), 3005–3009. CrossRef
23.
go back to reference Bradley, S., Rose, S., Lutgendorf, S., Costanzo, E., & Anderson, B. (2006). Quality of life and mental health in cervical and endometrial cancer survivors. Gynecologic Oncology, 100(3), 479–486. CrossRef Bradley, S., Rose, S., Lutgendorf, S., Costanzo, E., & Anderson, B. (2006). Quality of life and mental health in cervical and endometrial cancer survivors. Gynecologic Oncology, 100(3), 479–486. CrossRef
24.
go back to reference Fleer, J., Hoekstra, H. J., Sleijfer, D. T., Tuinman, M. A., Klip, E. C., & Hoekstra-Weebers, J. E. (2006). Quality of life of testicular cancer survivors and the relationship with socio-demographics, cancer-related variables, and life events. Supportive Care in Cancer, 14(3), 251–259. CrossRef Fleer, J., Hoekstra, H. J., Sleijfer, D. T., Tuinman, M. A., Klip, E. C., & Hoekstra-Weebers, J. E. (2006). Quality of life of testicular cancer survivors and the relationship with socio-demographics, cancer-related variables, and life events. Supportive Care in Cancer, 14(3), 251–259. CrossRef
25.
go back to reference Peuckmann, V., Ekholm, O., Rasmussen, N. K., et al. (2007). Health-related quality of life in long-term breast cancer survivors: Nationwide survey in Denmark. Breast Cancer Research and Treatment, 104(1), 39–46. CrossRef Peuckmann, V., Ekholm, O., Rasmussen, N. K., et al. (2007). Health-related quality of life in long-term breast cancer survivors: Nationwide survey in Denmark. Breast Cancer Research and Treatment, 104(1), 39–46. CrossRef
26.
go back to reference Wang, S., Hsu, S. H., Gross, C. P., et al. (2016). Association between time since cancer diagnosis and health-related quality of life: A population-level analysis. Value Health, 19, 631–638. CrossRef Wang, S., Hsu, S. H., Gross, C. P., et al. (2016). Association between time since cancer diagnosis and health-related quality of life: A population-level analysis. Value Health, 19, 631–638. CrossRef
27.
go back to reference Hays, R. D., & Morales, L. S. (2001). The RAND-36 measure of health-related quality of life. Annals of Medicine, 33, 350–357. CrossRef Hays, R. D., & Morales, L. S. (2001). The RAND-36 measure of health-related quality of life. Annals of Medicine, 33, 350–357. CrossRef
28.
go back to reference Paltiel, O., Marzec-Boguslawska, A., Soskolne, V., et al. (2004). Use of tranquilizers and sleeping pills among cancer patients is associated with a poorer quality of life. Quality of Life Research, 13(10), 1699–1706. CrossRef Paltiel, O., Marzec-Boguslawska, A., Soskolne, V., et al. (2004). Use of tranquilizers and sleeping pills among cancer patients is associated with a poorer quality of life. Quality of Life Research, 13(10), 1699–1706. CrossRef
29.
go back to reference Stein, M. B., & Barrett-Connor, E. (2002). Quality of life in older adults receiving medications for anxiety, depression or insomnia: Findings from a community-based study. American Journal of Geriatric Psychiatry, 10(5), 568–574. CrossRef Stein, M. B., & Barrett-Connor, E. (2002). Quality of life in older adults receiving medications for anxiety, depression or insomnia: Findings from a community-based study. American Journal of Geriatric Psychiatry, 10(5), 568–574. CrossRef
30.
go back to reference Liavaag, A. H., Dorum, A., Fossa, S. D., Trope, C., & Dahl, A. A. (2009). Morbidity associated with ‘self-rated health’ in epithelial ovarian cancer survivors. BMC Cancer, 9, 2. CrossRef Liavaag, A. H., Dorum, A., Fossa, S. D., Trope, C., & Dahl, A. A. (2009). Morbidity associated with ‘self-rated health’ in epithelial ovarian cancer survivors. BMC Cancer, 9, 2. CrossRef
31.
go back to reference Krebber, A. M., Jansen, F., Witte, B. I., et al. (2016). Stepped care targeting psychological distress in head and neck cancer and lung cancer patients: A randomized, controlled trial. Annals of Oncology, 27(9), 1754–1760. CrossRef Krebber, A. M., Jansen, F., Witte, B. I., et al. (2016). Stepped care targeting psychological distress in head and neck cancer and lung cancer patients: A randomized, controlled trial. Annals of Oncology, 27(9), 1754–1760. CrossRef
32.
go back to reference Yabroff, K. R., Warren, J. L., Banthin, J., et al. (2009). Comparison of approaches for estimating prevalence costs of care for cancer patients: What is the impact of data source? Medical Care, 47(7 Suppl 1), S64. CrossRef Yabroff, K. R., Warren, J. L., Banthin, J., et al. (2009). Comparison of approaches for estimating prevalence costs of care for cancer patients: What is the impact of data source? Medical Care, 47(7 Suppl 1), S64. CrossRef
33.
go back to reference Ereshefsky, L., & Sloan, D. M. (2009). Drug–drug interactions with the use of psychotropic medications. CNS Spectrums, 14(8), 1–8. PubMed Ereshefsky, L., & Sloan, D. M. (2009). Drug–drug interactions with the use of psychotropic medications. CNS Spectrums, 14(8), 1–8. PubMed
Metagegevens
Titel
Psychotropic polypharmacy and its association with health-related quality of life among cancer survivors in the USA: a population-level analysis
Auteurs
Ami Vyas
Ghadah Alghaith
Meghan Hufstader-Gabriel
Publicatiedatum
23-03-2020
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 8/2020
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-020-02478-6

Andere artikelen Uitgave 8/2020

Quality of Life Research 8/2020 Naar de uitgave